WELL Health Technologies (TSE:WELL) Given New C$5.25 Price Target at CIBC

WELL Health Technologies (TSE:WELL - Free Report) had its target price boosted by CIBC from C$5.00 to C$5.25 in a research note issued to investors on Friday,BayStreet.CA reports.

Separately, Ventum Financial dropped their target price on WELL Health Technologies from C$8.00 to C$7.00 and set a "buy" rating on the stock in a report on Tuesday, October 29th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of C$7.00.

WELL Health Technologies Stock Performance

WELL stock traded up C$0.41 on Friday, reaching C$5.34. The company's stock had a trading volume of 4,124,867 shares, compared to its average volume of 820,503. The firm has a fifty day moving average of C$4.45 and a two-hundred day moving average of C$4.33. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02. The company has a market capitalization of C$1.33 billion, a P/E ratio of 9.37, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a 52 week low of C$3.41 and a 52 week high of C$5.38.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.